PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Acerta Pharma BV
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
M.D. Anderson Cancer Center
Acerta Pharma BV
Ohio State University Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
French Innovative Leukemia Organisation
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Astellas Pharma Inc
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Eastern Cooperative Oncology Group
University of Pennsylvania
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
Northwestern University
Gilead Sciences
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Chinese PLA General Hospital
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center